iCELLigence real-time cell analysis system for examining the cytotoxicity of drugs to cancer cell lines.

Sener L., Albeniz G., Dinc B., Albeniz I.

Experimental and therapeutic medicine, vol.14, no.3, pp.1866-1870, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.3892/etm.2017.4781
  • Journal Name: Experimental and therapeutic medicine
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1866-1870
  • Istanbul University Affiliated: Yes

Abstract

The recently developed iCELLigence (TM) real-time cell analyzer (RTCA) can be used for the label-free real-time monitoring of cancer cell proliferation, viability, invasion and cytotoxicity. The RTCA system uses 16-well microtiter plates with a gold microelectrode biosensor array that measures impedance when cells adhere to the microelectrodes causing an alternating current. By measuring the electric field generated in this process, the RTCA system can be used for the analysis of cell proliferation, viability, morphology and migration. The present review aimed to summarize the working method of the RTCA system, in addition to discussing the research performed using the system for various applications, including cancer drug discovery via measuring cytotoxicity.